Niagen Bioscience, Inc. (NAGE)
NASDAQ: NAGE · Real-Time Price · USD
6.81
+0.28 (4.29%)
Apr 22, 2025, 1:48 PM EDT - Market open
Niagen Bioscience Market Cap
Niagen Bioscience has a market cap or net worth of $530.62 million as of April 22, 2025. Its market cap has increased by 63.12% in one year.
Market Cap
530.62M
Enterprise Value
480.97M
1-Year Change
63.12%
Ranking
Category
Stock Price
$6.81
Market Cap Chart
Since June 25, 2008, Niagen Bioscience's market cap has decreased from $909.70M to $530.62M, a decrease of -41.67%. That is a compound annual growth rate of -3.15%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 21, 2025 | 507.70M | 25.30% |
Dec 31, 2024 | 405.20M | 277.28% |
Dec 29, 2023 | 107.40M | -14.15% |
Dec 30, 2022 | 125.10M | -51.02% |
Dec 31, 2021 | 255.40M | -13.89% |
Dec 31, 2020 | 296.60M | 15.50% |
Dec 31, 2019 | 256.80M | 35.87% |
Dec 31, 2018 | 189.00M | -33.29% |
Dec 29, 2017 | 283.30M | 125.74% |
Dec 30, 2016 | 125.50M | -5.71% |
Dec 31, 2015 | 133.10M | 41.45% |
Dec 31, 2014 | 94.10M | -40.97% |
Dec 31, 2013 | 159.40M | 224.64% |
Dec 31, 2012 | 49.10M | 19.76% |
Dec 30, 2011 | 41.00M | -49.88% |
Dec 31, 2010 | 81.80M | 544.09% |
Dec 31, 2009 | 12.70M | -95.35% |
Dec 31, 2008 | 272.90M | -70.00% |
View and export this data all the way back to 2008.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 754.27B |
UnitedHealth Group | 415.38B |
Johnson & Johnson | 379.48B |
AbbVie | 306.02B |
Novo Nordisk | 284.50B |
Abbott Laboratories | 227.16B |
Novartis AG | 209.93B |
AstraZeneca | 208.11B |